Asymptomatic Primary Hyperparathyroidism.

2区医学 Q2 Medicine

Frontiers of Hormone Research Pub Date : 2019-01-01 Epub Date: 2018-11-19 DOI:10.1159/000491035

Bart L Clarke

引用次数: 12

Abstract

Asymptomatic primary hyperparathyroidism has become the most common presentation of primary hyperparathyroidism in Europe and North America, and an increasingly common presentation in other parts of the world. As many as 25% of asymptomatic patients may develop indications for parathyroidectomy when followed long-term for up to 15 years. Patients who remain asymptomatic should be monitored for the development of complications that justify surgery. Patients who become symptomatic should be referred for surgery. Surgery may improve quality of life even in patients who remain asymptomatic.

查看原文本刊更多论文

原发性无症状甲状旁腺功能亢进。

在欧洲和北美，无症状原发性甲状旁腺功能亢进已成为原发性甲状旁腺功能亢进最常见的表现，在世界其他地区也越来越常见。在长达15年的长期随访中，多达25%的无症状患者可能出现甲状旁腺切除术的适应症。对于无症状的患者，应监测其并发症的发展，以确定手术的合理性。出现症状的患者应转诊进行手术。手术甚至可以改善无症状患者的生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers of Hormone Research 医学-内分泌学与代谢

自引率

0.00%

发文量

期刊介绍： A series of integrated overviews on cutting-edge topics New sophisticated technologies and methodological approaches in diagnostics and therapeutics have led to significant improvements in identifying and characterizing an increasing number of medical conditions, which is particularly true for all aspects of endocrine and metabolic dysfunctions. Novel insights in endocrine physiology and pathophysiology allow for new perspectives in clinical management and thus lead to the development of molecular, personalized treatments. In view of this, the active interplay between basic scientists and clinicians has become fundamental, both to provide patients with the most appropriate care and to advance future research.